Inter-departmental Integration, R&D Intensity, and New Product Development Success: An Empirical Study of Bio-pharmaceutical Firms

Abstract

This empirical study examines the interplay between inter-departmental integration, research and development (R&D) intensity, and the success of new product development (NPD) initiatives within bio-pharmaceutical firms. Drawing upon organizational theory, innovation management, and pharmaceutical industry literature, this research investigates how the integration of various departments, such as research, development, marketing, and manufacturing, influences the effectiveness of NPD processes and outcomes. Furthermore, this study explores the role of R&D intensity, measured by investment in R&D activities relative to firm revenue, in shaping the relationship between inter-departmental integration and NPD success. Using quantitative analysis techniques applied to survey data collected from a sample of bio-pharmaceutical firms, this research examines the direct and moderating effects of inter-departmental integration and R&D intensity on NPD success metrics, including product launch success rates, time-to-market, and market performance. The findings offer insights into the organizational factors and strategic priorities that contribute to successful NPD initiatives in the highly competitive and dynamic bio-pharmaceutical industry. Moreover, this study provides practical implications for bio-pharmaceutical firms seeking to enhance their NPD capabilities and achieve sustainable competitive advantage through effective inter-departmental collaboration and strategic R&D investment.